Re-imagining research and business intelligence for biomedicine

Used by top pharma companies and academic researchers, Prism’s configurable data science platform will let you analyze your data to extract 10x the insights at 50x the speed!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Prism solutions span the R&D lifecycle

What our clients say:

“I’d never seen anything like Prism’s platform. This is a game-changer for our digital health strategy.”

Director, Clinical Innovation

Top 3 Pharma Company

“My only regret is that we didn’t start working with Prism sooner.”

Director, Data Science

Top 3 Pharma Company

“We already spend hundreds of thousands of dollars on research. Prism helps us get more value of it.”

Vice President, Market Access

Top 3 Pharma Company

“Prism’s data management really is everything you would want in a platform.”

Executive Director

N.I.H.-funded Research Network

“We’ve worked with other data science and analytics companies, but none of them have the spark that Prism does.”

Head of Global Innovation

Top 10 Pharma Company

“Working with Prism was fast, fun, and painless. I wish all of my projects could be like that!”

Assistant Professor

Canadian R1 University

Benefits of the Prism platform

Flexibility

Specify your data and hypothesis and our platform produces a holistic view of that universe–no data gaps!

Speed

Get up and running fast with dynamic analyses and real-time updates. No need to juggle apps or maintain your own software.

Insight

Surface insights and drill down on questions with a few clicks. Our UI makes it easy to test and revise hypotheses.

Rigor

We use transparent data science methods, validated over years of peer review. You can be confident about the conclusions you draw from data.

Explore the platform for yourself

You can experience the look and feel of our product right now by checking out some of these incredible public-facing projects on our platform

Digital Health Technologies in Trials

Opioid-Use Disorder Evidence Map

Landscape of Terminated Trials

In collaboration with Janssen, we replicated and fully automated a 2020 study that estimated the number of trials that use digital health technologies.

A team of researchers at NYU conducted a systematic literature review for all the available evidence on treatments for opioid use disorder. They used Prism’s platform to analyze and disseminate the results.

We created a heuristic-based natural language processing algorithm to analyze and classify all the terminated clinical trials from the past 12 years.

Our Vision

We envision a world where evidence synthesis is always up to date with the latest research data‍
Where you no longer have to waste time harmonizing data sources, because all that work has been done for you
Where you can immediately drill down and inspect raw data
Where your analysis can automatically update to reflect a change in your hypothesis.
If you share this vision, then let’s start working together to make it a reality!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.